Symeres B.V.
Kerkenbos 1013
6546 BB Nijmegen
NL
Symeres B.V.
Foundation date
25/06/1997
Sector
#Biotechnology / R&D ServicesSubsector
- #R&D Services - CMO (Contract Manufacturing Organization)
- #R&D Services - CRO (Contract Research Organization)
Therapeutic areas
- #Cardiovascular
- #Digestive system
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the ear
- #Diseases of the eye
- #Diseases of the nervous system
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Injury - poisoning and certain other consequences of external causes
- #Mental and behavioural disorders
- #Neoplasms / cancer / oncology
- #Respiratory system
- #Skin and subcutaneous tissue
We are a CRO for services in synthetic chemistry. We offer the following services:
Discovery Chemistry;
Medicinal Chemistry;
Parallel Chemistry;
Scale-up Synthesis;
Process Chemistry, including GMP synthesis up to a few kg.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
9 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
1 day ago
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator